Metabolic dysfunction-associated steatotic liver disease prevalence

1 paper1 finding

Humans1

Associations

1

Serum uric acid

upin humans1OR 1.26

1 study

Serum uric acid is associated with metabolic dysfunction-associated steatotic liver disease prevalence in humans (OR 1.26 per 1 mg/dL, 95% CI 1.22–1.31; attenuation at higher concentrations).
HumansPrimary adjusted model; per 1 mg/dL above the population-weighted mean serum uric acid of 5.38 mg/dLn = 28,199
Serum Uric Acid and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Two-Stage NHANES Study of MASLD Prevalence and All-Cause Mortality
Metabolic syndrome and related disorders8 Oct 2026

More on Serum uric acid

Latest

2 in 12 months

Metabolic Syndrome and Related Disorders8 Oct

Serum Uric Acid and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Two-Stage NHANES Study of MASLD Prevalence and All-Cause Mortality

Cohort study of 28,199 peopleSerum uric acid

Research Square26 Aug

Insulin-to-HDL-C Ratio as a Simple and Reliable Surrogate Marker of Metabolic dysfunction-associated steatotic liver disease Prevalence, Steatosis Severity, and Metabolic Burden: A Cross-Sectional Comparison with Established Insulin Resistance Indices

Preprint: cross-sectional study of 1,735 peopleHDL-C